163 related articles for article (PubMed ID: 21342138)
1. Cartilage oligomeric matrix protein - inflammation biomarker in knee osteoarthritis.
Zivanović S; Rackov LP; Zivanović A; Jevtić M; Nikolić S; Kocić S
Bosn J Basic Med Sci; 2011 Feb; 11(1):27-32. PubMed ID: 21342138
[TBL] [Abstract][Full Text] [Related]
2. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis.
Vilím V; Vytásek R; Olejárová M; Machácek S; Gatterová J; Procházka B; Kraus VB; Pavelka K
Osteoarthritis Cartilage; 2001 Oct; 9(7):612-8. PubMed ID: 11597173
[TBL] [Abstract][Full Text] [Related]
3. Associations between suprapatellar pouch effusion-synovitis, serum cartilage oligomeric matrix protein, high sensitivity C-reaction protein, knee symptom, and joint structural changes in patients with knee osteoarthritis.
Yang X; Ruan G; Xu J; Zheng S; Wang K; Ding C
Clin Rheumatol; 2020 May; 39(5):1663-1670. PubMed ID: 31897961
[TBL] [Abstract][Full Text] [Related]
4. Correlation of sonographic severity with biochemical markers of synovium and cartilage in knee osteoarthritis patients.
Jung YO; Do JH; Kang HJ; Yoo SA; Yoon CH; Kim HA; Cho CS; Kim WU
Clin Exp Rheumatol; 2006; 24(3):253-9. PubMed ID: 16870091
[TBL] [Abstract][Full Text] [Related]
5. Whole-body bone scintigraphy provides a measure of the total-body burden of osteoarthritis for the purpose of systemic biomarker validation.
Addison S; Coleman RE; Feng S; McDaniel G; Kraus VB
Arthritis Rheum; 2009 Nov; 60(11):3366-73. PubMed ID: 19877068
[TBL] [Abstract][Full Text] [Related]
6. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project.
Clark AG; Jordan JM; Vilim V; Renner JB; Dragomir AD; Luta G; Kraus VB
Arthritis Rheum; 1999 Nov; 42(11):2356-64. PubMed ID: 10555031
[TBL] [Abstract][Full Text] [Related]
7. Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker.
Verma P; Dalal K
J Orthop Res; 2013 Jul; 31(7):999-1006. PubMed ID: 23423905
[TBL] [Abstract][Full Text] [Related]
8. Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication.
Wisłowska M; Jabłońska B
Rheumatol Int; 2005 Jun; 25(5):373-8. PubMed ID: 15739097
[TBL] [Abstract][Full Text] [Related]
9. Associations between cartilage oligomeric matrix protein and several articular tissues in early knee joint osteoarthritis.
Kumm J; Tamm A; Veske K; Lintrop M; Tamm A
Rheumatology (Oxford); 2006 Oct; 45(10):1308-9. PubMed ID: 16920749
[No Abstract] [Full Text] [Related]
10. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
Wisłowska M; Jabłońska B
Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
[TBL] [Abstract][Full Text] [Related]
11. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
[TBL] [Abstract][Full Text] [Related]
12. Association between Markers of Synovial Inflammation, Matrix Turnover and Symptoms in Knee Osteoarthritis: A Cross-Sectional Study.
Yang X; Thudium CS; Bay-Jensen AC; Karsdal MA; van Santen J; Arden NK; Perry TA; Kluzek S
Cells; 2021 Jul; 10(7):. PubMed ID: 34359996
[TBL] [Abstract][Full Text] [Related]
13. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.
Senolt L; Braun M; Olejárová M; Forejtová S; Gatterová J; Pavelka K
Ann Rheum Dis; 2005 Jun; 64(6):886-90. PubMed ID: 15897309
[TBL] [Abstract][Full Text] [Related]
14. Serum cartilage oligomeric matrix protein (COMP) expression in individuals who sustained a youth sport-related intra-articular knee injury 3-10 years previously and uninjured matched controls.
Laudon J; Whittaker JL; Ren G; Jaremko JL; Emery CA; Krawetz RJ
Osteoarthritis Cartilage; 2019 Feb; 27(2):286-293. PubMed ID: 30317002
[TBL] [Abstract][Full Text] [Related]
15. Serum cartilage oligomeric matrix protein and other biomarker profiles in tibiofemoral and patellofemoral osteoarthritis of the knee.
Sharif M; Granell R; Johansen J; Clarke S; Elson C; Kirwan JR
Rheumatology (Oxford); 2006 May; 45(5):522-6. PubMed ID: 16319098
[TBL] [Abstract][Full Text] [Related]
16. A relationship between mechanically-induced changes in serum cartilage oligomeric matrix protein (COMP) and changes in cartilage thickness after 5 years.
Erhart-Hledik JC; Favre J; Asay JL; Smith RL; Giori NJ; Mündermann A; Andriacchi TP
Osteoarthritis Cartilage; 2012 Nov; 20(11):1309-15. PubMed ID: 22868052
[TBL] [Abstract][Full Text] [Related]
17. Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation.
Fernandes FA; Pucinelli ML; da Silva NP; Feldman D
Scand J Rheumatol; 2007; 36(3):211-5. PubMed ID: 17657676
[TBL] [Abstract][Full Text] [Related]
18. Human cartilage glycoprotein 39--biomarker of joint damage in knee osteoarthritis.
Zivanović S; Rackov LP; Vojvodić D; Vucetić D
Int Orthop; 2009 Aug; 33(4):1165-70. PubMed ID: 19308408
[TBL] [Abstract][Full Text] [Related]
19. Persistent high serum levels of cartilage oligomeric matrix protein in a subgroup of patients with traumatic knee injury.
Kühne SA; Neidhart M; Everson MP; Häntzschel H; Fine PR; Gay S; Häuselmann HJ; Gay RE
Rheumatol Int; 1998; 18(1):21-5. PubMed ID: 9672995
[TBL] [Abstract][Full Text] [Related]
20. Concentrations of cartilage oligomeric matrix protein in dogs with naturally developing and experimentally induced arthropathy.
Misumi K; Vilim V; Carter SD; Ichihashi K; Oka T; Sakamoto H
Am J Vet Res; 2002 Apr; 63(4):598-603. PubMed ID: 11939326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
